Recently, we demonstrated that CD34+CD38− stem cells expressing abnormal immunophenotypes similar to LAIPs, so-called immunophenotypic aberrant HSCs (IA-HSCs), predict leukaemic progression in MDS [20]. This evidence concerns the gene CD34 and myelodysplastic syndrome.